In 78 adults with severe COVID-19 in intensive care (73 analysed), adding losartan with conditional spironolactone to standard care did not significantly change median SOFA score at day 7 (3 vs 2; p=0.5); trial stopped early and underpowered.
RCTn = 78
Simeone et al. Losartan with add-on spironolactone for severe COVID-19 in the intensive care unit: a randomized controlled trial